170 related articles for article (PubMed ID: 34378123)
1. Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer.
Capriglione F; Verrienti A; Celano M; Maggisano V; Sponziello M; Pecce V; Gagliardi A; Giacomelli L; Aceti V; Durante C; Bulotta S; Russo D
Endocrine; 2022 Jan; 75(1):185-193. PubMed ID: 34378123
[TBL] [Abstract][Full Text] [Related]
2. Exosome-mediated Delivery of miR-519e-5p Promotes Malignant Tumor Phenotype and CD8+ T-Cell Exhaustion in Metastatic PTC.
Li G; Chen W; Jiang K; Huang J; Zhong J; Liu X; Wei T; Gong R; Li Z; Zhu J; Shi H; Lei J
J Clin Endocrinol Metab; 2024 May; 109(6):1601-1617. PubMed ID: 38078691
[TBL] [Abstract][Full Text] [Related]
3. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.
Dai D; Tan Y; Guo L; Tang A; Zhao Y
Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
6. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.
Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J
Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998
[TBL] [Abstract][Full Text] [Related]
7. Subpopulations of exosomes purified via different exosomal markers carry different microRNA contents.
Wu SC; Kuo PJ; Rau CS; Wu YC; Wu CJ; Lu TH; Lin CW; Tsai CW; Hsieh CH
Int J Med Sci; 2021; 18(4):1058-1066. PubMed ID: 33456364
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-based molecular classification of papillary thyroid carcinoma.
Rosignolo F; Memeo L; Monzani F; Colarossi C; Pecce V; Verrienti A; Durante C; Grani G; Lamartina L; Forte S; Martinetti D; Giuffrida D; Russo D; Basolo F; Filetti S; Sponziello M
Int J Oncol; 2017 May; 50(5):1767-1777. PubMed ID: 28393181
[TBL] [Abstract][Full Text] [Related]
9. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serum exosome isolation methods for microRNA profiling.
Rekker K; Saare M; Roost AM; Kubo AL; Zarovni N; Chiesi A; Salumets A; Peters M
Clin Biochem; 2014 Jan; 47(1-2):135-8. PubMed ID: 24183884
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma: a potential diagnostic and biological target for cancer therapy.
Ye W; Deng X; Fan Y
Neoplasma; 2019 Jul; 66(4):516-523. PubMed ID: 30868891
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
14. Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.
Lee JC; Zhao JT; Gundara J; Serpell J; Bach LA; Sidhu S
J Surg Res; 2015 Jun; 196(1):39-48. PubMed ID: 25819770
[TBL] [Abstract][Full Text] [Related]
15. Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells.
Maggisano V; Capriglione F; Verrienti A; Celano M; Gagliardi A; Bulotta S; Sponziello M; Mio C; Pecce V; Durante C; Damante G; Russo D
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625697
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
[No Abstract] [Full Text] [Related]
17. Exosomes increased angiogenesis in papillary thyroid cancer microenvironment.
Wu F; Li F; Lin X; Xu F; Cui RR; Zhong JY; Zhu T; Shan SK; Liao XB; Yuan LQ; Mo ZH
Endocr Relat Cancer; 2019 May; 26(5):525-538. PubMed ID: 30870812
[TBL] [Abstract][Full Text] [Related]
18. Proteomics study of serum exosomes from papillary thyroid cancer patients.
Luo D; Zhan S; Xia W; Huang L; Ge W; Wang T
Endocr Relat Cancer; 2018 Oct; 25(10):879-891. PubMed ID: 29895528
[TBL] [Abstract][Full Text] [Related]
19. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
20. A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis.
Zou X; Gao F; Wang ZY; Zhang H; Liu QX; Jiang L; Zhou X; Zhu W
Chin Med J (Engl); 2020 Nov; 133(21):2543-2551. PubMed ID: 33009019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
